Mokan Wealth Management Inc. Exelixis, Inc. Transaction History
Mokan Wealth Management Inc.
- $225 Billion
- Q4 2025
A detailed history of Mokan Wealth Management Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Mokan Wealth Management Inc. holds 6,067 shares of EXEL stock, worth $252,690. This represents 0.12% of its overall portfolio holdings.
Number of Shares
6,067
Previous 4,981
21.8%
Holding current value
$252,690
Previous $206 Million
29.32%
% of portfolio
0.12%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
701Shares Held
258MCall Options Held
1.5MPut Options Held
1.71M-
Black Rock Inc. New York, NY33.5MShares$1.4 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.1MShares$1.09 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA19.5MShares$812 Million3.48% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.5MShares$644 Million0.9% of portfolio
-
State Street Corp Boston, MA11.1MShares$463 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $13.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...